Health
Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals – News-Medical.Net
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection…
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection against coronavirus disease 2019 (COVID-19) over one dose among individuals previously infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
In a study evaluating immune responses to the Pfizer-BioNTech vaccine, Ramin Herati and colleagues observed robust humoral (antibody) responses following two…
-
General21 hours agoVictorian school teacher charged with soliciting child abuse material
-
General13 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News18 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News17 hours agoPalestine protesters forced into last-minute reroute